1 Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, affecting ~30% of the adult population [1]. It represents a disease spectrum ranging from simple steatosis and steatohepatitis through to progressive fibrosis and cirrhosis, with an annual fibrosis progression rate of 0.9% [2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jo
Contact Jo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack